Brian G Gabrielli (Brian Gabrielli)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

International journal of molecular sciences

British journal of cancer

Cancers

Pigment cell & melanoma research

The University of Queensland

La Trobe University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Queensland

Australia

Head, Cancer Program :: Diamanatina Institute

Education History

La Trobe University

Australia

PHD :: Biochemistry

James Cook University

Australia

BSC :: Biochemistry

Publications

Esha T Shah, Christopher Molloy, Madeline Gough, Thomas Kryza, Selwin G Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian G Gabrielli, John D Hooper, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British journal of cancer (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Esha T Shah, Christopher Molloy, Madeline Gough, Thomas Kryza, Selwin G Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian G Gabrielli, John D Hooper, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British journal of cancer 130 (7) (2024)
Esha T Shah, Christopher Molloy, Madeline Gough, Thomas Kryza, Selwin G Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian G Gabrielli, John D Hooper, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British journal of cancer 130 (7) (2024)
Esha T Shah, Christopher Molloy, Madeline Gough, Thomas Kryza, Selwin G Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian G Gabrielli, John D Hooper, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British journal of cancer 130 (7) (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Esha T Shah, Christopher Molloy, Madeline Gough, Thomas Kryza, Selwin G Samuel, Amos Tucker, Maneet Bhatia, Genevieve Ferguson, Rebecca Heyman, Shivam Vora, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian G Gabrielli, John D Hooper, Derek J Richard, Kenneth J O'Byrne, Mark Nathaniel Adams
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British journal of cancer 130 (7) (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor, Catherine Lanagan, Alexander J Stevenson, Farhad Dehkhoda, Mary Caole, Ellie J Maas, Stephen Ainger, Antonia L Pritchard, Peter A Johansson, Paul Leo, Nicholas K Hayward, Richard A Sturm, Emma L Duncan, Brian G Gabrielli
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence. International journal of molecular sciences 25 (3) (2024)
Zhen Zeng, Hung Long Ngo, Martina Proctor, Helen Rizos, Riccardo Dolcetti, Jazmina Gonzalez Cruz, James W Wells, Brian G Gabrielli
Checkpoint kinase 1 inhibitor + low-dose hydroxyurea efficiently kills BRAF inhibitor- and immune checkpoint inhibitor-resistant melanomas. Pigment cell & melanoma research (2023)
Debottam Sinha, Philip Moseley, Xuehan Lu, Quentin G Wright, Brian G Gabrielli, Ian Hector Frazer, Jazmina L G Cruz
Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade. Cancers 14 (24) (2022)
Debottam Sinha, Philip Moseley, Xuehan Lu, Quentin G Wright, Brian G Gabrielli, Ian Hector Frazer, Jazmina L G Cruz
Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade. Cancers 14 (24) (2022)
Madushan Fernando, Pascal H G Duijf, Martina Proctor, Alexander J Stevenson, Anna Ehmann, Shivam Vora, Dubravka Škalamera, Mark Nathaniel Adams, Brian G Gabrielli
Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours. Oncogenesis 10 (5) (2021)
Martina Proctor, Jazmina L G Cruz, Sheena M Daignault-Mill, Margaret Veitch, Bijun Zeng, Anna Ehmann, Muhammed Sabdia, Cameron E Snell, Colm Keane, Riccardo Dolcetti, Nikolas K Haass, James W Wells, Brian G Gabrielli
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers 13 (15) (2021)
Sandra Pavey, Alex Pinder, Winnie Fernando, Nicholas D'Arcy, Nicholas Matigian, Dubravka Skalamera, Kim-Anh Lê Cao, Dorothy Loo-Oey, Michelle M Hill, Mitchell S Stark, Michael Kimlin, Andrew Burgess, Nicole Cloonan, Richard A Sturm, Brian G Gabrielli
Multiple interaction nodes define the postreplication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load. Molecular oncology 14 (1) (2019)
Claire Levrier, Anja Rockstroh, Brian G Gabrielli, Maria Kavallaris, Melanie L Lehman, Rohan A Davis, Martin C Sadowski, Colleen C Nelson
Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells. Cell cycle (Georgetown, Tex.) 17 (5) (2019)
Alexander J Stevenson, Eleanor I Ager, Martina A Proctor, Dubravka Škalamera, Andrew Heaton, David Brown, Brian G Gabrielli
Mechanism of action of the third generation benzopyrans and evaluation of their broad anti-cancer activity in vitro and in vivo. Scientific reports 8 (1) (2018)
Nicholas D'Arcy, Nicholas Matigian, Kim-Anh Lê Cao, Brian G Gabrielli
Pathway dysregulation analysis of the nucleotide excision repair mechanisms reveals it is not a common feature of melanomas. Pigment cell & melanoma research 32 (2) (2018)

Brian G Gabrielli.css-eqlu8i{font-size:small;padding-left:4px;} (Brian Gabrielli)

Publication Activity (10 Years)

Top Topics

Top Venues

Brian G Gabrielli (Brian Gabrielli)